# Nasdaq:IRD news releases

Nasdaq:IRD press releases distributed through Connectively Wire to the journalists who cover the beat.

- **Releases in the last 90 days:** 271
- **Web page:** https://www.connectively.us/news-releases/nasdaqird
- **RSS:** https://www.connectively.us/news-releases/nasdaqird/rss.xml

### [Opus Genetics Announces First Participant Dosed in Phase 1/2 Clinical Trial of OPGx-RDH12 Gene Therapy for Rare Inherited Childhood Blindness](https://www.connectively.us/news-releases/opus-genetics-announces-first-participant-dosed-in-phase-12-clinical)

November 19, 2026 · Opus Genetics · Nasdaq:IRD

First participant dosed with OPGx-RDH12, an investigational gene therapy designed to address the underlying genetic cause of RDH12-associated Leber congenital amaurosis (RDH12-LCA) Milestone advances Opus Genetics' third gene therapy program into clinical development, following…
